Biotech · Private company
AOBiome LLC
Track this companyFree. Adds AOBiome LLC to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- B244Phase 3 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- B244Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- B244Phase 2 · Atopic Dermatitis EczemaClinicalTrials.gov · fetched Nov 12, 2026
- B244Phase 2 · RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- B244Phase 2 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- B244Phase 2 · PrehypertensionClinicalTrials.gov · fetched Nov 12, 2026
- B244 suspensionPhase 2 · Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · RosaceaClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Atopic Dermatitis EczemaClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · PrehypertensionClinicalTrials.gov · fetched Nov 12, 2026
- Experimental: B244Phase 1 · EczemaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic DermatitisPHASE2 · COMPLETED · started Jun 24, 2020ClinicalTrials.gov NCT04490109 · fetched Nov 12, 2026
- A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic DermatitisPHASE1 · COMPLETED · started Dec 7, 2018ClinicalTrials.gov NCT03775434 · fetched Nov 12, 2026
- A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate RosaceaPHASE2 · COMPLETED · started Jul 2, 2018ClinicalTrials.gov NCT03590366 · fetched Nov 12, 2026
- Study to Determine Safety and Efficacy of B244 in Subjects With Episodic MigrainePHASE2 · COMPLETED · started Mar 30, 2018ClinicalTrials.gov NCT03488563 · fetched Nov 12, 2026
- Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic DermatitisPHASE2 · COMPLETED · started Jan 15, 2018ClinicalTrials.gov NCT03235024 · fetched Nov 12, 2026
- Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic RhinitisPHASE1_PHASE2 · COMPLETED · started Sep 19, 2017ClinicalTrials.gov NCT03290248 · fetched Nov 12, 2026
- A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood PressurePHASE2 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02998840 · fetched Nov 12, 2026
- Clinical Trial in Subjects With Mild to Moderate Acne VulgarisPHASE2_PHASE3 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02832063 · fetched Nov 12, 2026